- Home
- QURE vs CGC Comparison
QURE vs CGC Comparison
Compare QURE & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- CGC
- Stock Information
- Founded
- QURE 1998
- CGC 2009
- Country
- QURE Netherlands
- CGC Canada
- Employees
- QURE N/A
- CGC N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- CGC Pharmaceuticals and Biotechnology
- Sector
- QURE Health Care
- CGC Health Care
- Exchange
- QURE Nasdaq
- CGC Nasdaq
- Market Cap
- QURE 432.6M
- CGC 446.7M
- IPO Year
- QURE 2007
- CGC N/A
- Fundamental
- Price
- QURE $5.85
- CGC $3.86
- Analyst Decision
- QURE Buy
- CGC Sell
- Analyst Count
- QURE 6
- CGC 1
- Target Price
- QURE $17.00
- CGC $2.00
- AVG Volume (30 Days)
- QURE 792.5K
- CGC 7.3M
- Earning Date
- QURE 11-05-2024
- CGC 11-08-2024
- Dividend Yield
- QURE N/A
- CGC N/A
- EPS Growth
- QURE N/A
- CGC N/A
- EPS
- QURE N/A
- CGC N/A
- Revenue
- QURE $28,587,000.00
- CGC $207,628,706.00
- Revenue This Year
- QURE $157.96
- CGC N/A
- Revenue Next Year
- QURE N/A
- CGC $7.76
- P/E Ratio
- QURE N/A
- CGC N/A
- Revenue Growth
- QURE N/A
- CGC N/A
- 52 Week Low
- QURE $3.73
- CGC $2.76
- 52 Week High
- QURE $11.35
- CGC $14.92
- Technical
- Relative Strength Index (RSI)
- QURE 43.86
- CGC 40.32
- Support Level
- QURE $5.50
- CGC $3.75
- Resistance Level
- QURE $7.96
- CGC $3.88
- Average True Range (ATR)
- QURE 0.59
- CGC 0.35
- MACD
- QURE -0.16
- CGC -0.07
- Stochastic Oscillator
- QURE 18.97
- CGC 10.60
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.